The Cellular and Molecular Basis of Translational Immunometabolism

Immunity

Volumn 43, Issue 3, 2015, Pages 421-434

  Norata, Giuseppe Danilo ^a,b   Caligiuri, Giuseppina ^c,d,e   Chavakis, Triantafyllos ^f   Matarese, Giuseppe ^g,h   Netea, Mihai Gheorge ⁱ   Nicoletti, Antonino ^f   O'Neill, Luke A J ^j   Marelli Berg, Federica M ^k  

^a UNIVERSITY OF MILAN   (Italy)

^b Bassini Hospital   (Italy)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Dé Partement Hospitalo Universitaire FIRE   (France)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF SALERNO   (Italy)

^h IRCCS MULTIMEDICA   (Italy)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j TRINITY COLLEGE DUBLIN   (Ireland)

^k QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN;

AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; CELL MIGRATION; CELL SUBPOPULATION; CHOLESTEROL METABOLISM; DIABETES MELLITUS; DRUG METABOLISM; DRUG TARGETING; FATTY ACID METABOLISM; HUMAN; HYPERLIPIDEMIA; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPHENOTYPING; INNATE IMMUNITY; INTESTINE FLORA; METABOLIC DISORDER; METABOLIC REGULATION; METABOLISM; MOLECULAR DYNAMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; TRANSLATIONAL IMMUNOMETABOLISM; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; ENERGY METABOLISM; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; MACROPHAGE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ENERGY METABOLISM; HUMANS; IMMUNE SYSTEM; MACROPHAGES; METABOLIC DISEASES; METABOLIC NETWORKS AND PATHWAYS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTE SUBSETS;

EID: 84941637376     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.08.023     Document Type: Review

References (173)

1. Aktas O., Waiczies S., Smorodchenko A., Dorr J., Seeger B., Prozorovski T., Sallach S., Endres M., Brocke S., Nitsch R., Zipp F. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 2003, 197:725-733.
2. Amano S.U., Cohen J.L., Vangala P., Tencerova M., Nicoloro S.M., Yawe J.C., Shen Y., Czech M.P., Aouadi M. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab. 2014, 19:162-171.
3. Ammirati E., Cianflone D., Banfi M., Vecchio V., Palini A., De Metrio M., Marenzi G., Panciroli C., Tumminello G., Anzuini A., et al. Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1832-1841.
4. Ammirati E., Cianflone D., Vecchio V., Banfi M., Vermi A.C., De Metrio M., Grigore L., Pellegatta F., Pirillo A., Garlaschelli K., et al. Effector memory T cells are associated with atherosclerosis in humans and animal models. J. Am. Heart Assoc. 2012, 1:27-41.
5. Aouadi M., Vangala P., Yawe J.C., Tencerova M., Nicoloro S.M., Cohen J.L., Shen Y., Czech M.P. Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance. Am. J. Physiol. Endocrinol. Metab. 2014, 307:E374-E383.
6. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., Rudensky A.Y. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
7. Arts R.J., Blok B.A., van Crevel R., Joosten L.A., Aaby P., Benn C.S., Netea M.G. Vitamin A induces inhibitory histone methylation modifications and down-regulates trained immunity in human monocytes. J. Leukoc. Biol. 2015, 98:129-136.
8. Bernstein B.W., Bamburg J.R. Actin-ATP hydrolysis is a major energy drain for neurons. J. Neurosci. 2003, 23:1-6.
9. Bie J., Zhao B., Marqueen K.E., Wang J., Szomju B., Ghosh S. Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E1283-E1291.
10. Bieghs V., Walenbergh S.M., Hendrikx T., van Gorp P.J., Verheyen F., Olde Damink S.W., Masclee A.A., Koek G.H., Hofker M.H., Binder C.J., Shiri-Sverdlov R. Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation. Liver Int. 2013, 33:1056-1061.
11. Brestoff J.R., Kim B.S., Saenz S.A., Stine R.R., Monticelli L.A., Sonnenberg G.F., Thome J.J., Farber D.L., Lutfy K., Seale P., Artis D. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015, 519:242-246.
12. Brooks-Worrell B., Narla R., Palmer J.P. Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obes. Metab. 2013, 15(Suppl 3):137-140.
13. Caballero A.E., Delgado A., Aguilar-Salinas C.A., Herrera A.N., Castillo J.L., Cabrera T., Gomez-Perez F.J., Rull J.A. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial. J. Clin. Endocrinol. Metab. 2004, 89:3943-3948.
14. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
15. Carbone F., De Rosa V., Carrieri P.B., Montella S., Bruzzese D., Porcellini A., Procaccini C., La Cava A., Matarese G. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 2014, 20:69-74.
16. Castrillo A., Joseph S.B., Vaidya S.A., Haberland M., Fogelman A.M., Cheng G., Tontonoz P. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 2003, 12:805-816.
17. Catapano A.L., Pirillo A., Bonacina F., Norata G.D. HDL in innate and adaptive immunity. Cardiovasc. Res. 2014, 103:372-383.
18. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
19. Chataway J., Schuerer N., Alsanousi A., Chan D., MacManus D., Hunter K., Anderson V., Bangham C.R., Clegg S., Nielsen C., et al. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 2014, 383:2213-2221.
20. Chatzigeorgiou A., Chavakis T. Immune cells and metabolism. Handbook Exp. Pharmacol. 2015, 10.1007/164_2015_8.
21. Chatzigeorgiou A., Karalis K.P., Bornstein S.R., Chavakis T. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012, 55:2583-2592.
22. Chatzigeorgiou A., Chung K.J., Garcia-Martin R., Alexaki V.I., Klotzsche-von Ameln A., Phieler J., Sprott D., Kanczkowski W., Tzanavari T., Bdeir M., et al. Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology 2014, 60:1196-1210.
23. Chatzigeorgiou A., Seijkens T., Zarzycka B., Engel D., Poggi M., van den Berg S., van den Berg S., Soehnlein O., Winkels H., Beckers L., et al. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proc. Natl. Acad. Sci. USA 2014, 111:2686-2691.
24. Cheng S.C., Quintin J., Cramer R.A., Shepardson K.M., Saeed S., Kumar V., Giamarellos-Bourboulis E.J., Martens J.H., Rao N.A., Aghajanirefah A., et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014, 345:1250684.
25. Chien J.Y., Jerng J.S., Yu C.J., Yang P.C. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit. Care Med. 2005, 33:1688-1693.
26. Chmelar J., Chung K.J., Chavakis T. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thromb. Haemost. 2013, 109:399-406.
27. Cipolletta D., Feuerer M., Li A., Kamei N., Lee J., Shoelson S.E., Benoist C., Mathis D. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012, 486:549-553.
28. Cipolletta D., Cohen P., Spiegelman B.M., Benoist C., Mathis D. Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARγ effects. Proc. Natl. Acad. Sci. USA 2015, 112:482-487.
29. Colegio O.R., Chu N.Q., Szabo A.L., Chu T., Rhebergen A.M., Jairam V., Cyrus N., Brokowski C.E., Eisenbarth S.C., Phillips G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 2014, 513:559-563.
30. Coppé J.P., Patil C.K., Rodier F., Sun Y., Muñoz D.P., Goldstein J., Nelson P.S., Desprez P.Y., Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6:2853-2868.
31. Dandona P., Aljada A., Ghanim H., Mohanty P., Tripathy C., Hofmeyer D., Chaudhuri A. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J. Clin. Endocrinol. Metab. 2004, 89:5043-5047.
32. Daniel J.L., Molish I.R., Robkin L., Holmsen H. Nucleotide exchange between cytosolic ATP and F-actin-bound ADP may be a major energy-utilizing process in unstimulated platelets. Eur. J. Biochem. 1986, 156:677-684.
33. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 2003, 133(7, Suppl):2485S-2493S.
34. De Nardo D., Labzin L.I., Kono H., Seki R., Schmidt S.V., Beyer M., Xu D., Zimmer S., Lahrmann C., Schildberg F.A., et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 2014, 15:152-160.
35. De Rosa V., Procaccini C., Calì G., Pirozzi G., Fontana S., Zappacosta S., La Cava A., Matarese G. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007, 26:241-255.
36. Delamaire M., Maugendre D., Moreno M., Le Goff M.C., Allannic H., Genetet B. Impaired leucocyte functions in diabetic patients. Diabet. Med. 1997, 14:29-34.
37. Delzenne N.M., Neyrinck A.M., Bäckhed F., Cani P.D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 2011, 7:639-646.
38. Diomede L., Albani D., Sottocorno M., Donati M.B., Bianchi M., Fruscella P., Salmona M. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1327-1332.
39. Dorrestein P.C., Mazmanian S.K., Knight R. Finding the missing links among metabolites, microbes, and the host. Immunity 2014, 40:824-832.
40. Dunn S.E., Youssef S., Goldstein M.J., Prod'homme T., Weber M.S., Zamvil S.S., Steinman L. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J. Exp. Med. 2006, 203:401-412.
41. Dusseaux M., Martin E., Serriari N., Péguillet I., Premel V., Louis D., Milder M., Le Bourhis L., Soudais C., Treiner E., Lantz O. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011, 117:1250-1259.
42. Duval C., Müller M., Kersten S. PPARalpha and dyslipidemia. Biochim. Biophys. Acta 2007, 1771:961-971.
43. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J. Leukoc. Biol. 2010, 87:989-999.
44. Fabrizi M., Marchetti V., Mavilio M., Marino A., Casagrande V., Cavalera M., Moreno-Navarrete J.M., Mezza T., Sorice G.P., Fiorentino L., et al. IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity. Diabetes 2014, 63:2086-2096.
45. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A.B., Benoist C., Shoelson S., Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15:930-939.
46. Finlay D., Cantrell D.A. Metabolism, migration and memory in cytotoxic T cells. Nat. Rev. Immunol. 2011, 11:109-117.
47. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., Nakanishi Y., Uetake C., Kato K., Kato T., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
48. Gallacher S.J., Thomson G., Fraser W.D., Fisher B.M., Gemmell C.G., MacCuish A.C. Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet. Med. 1995, 12:916-920.
49. Gatza E., Wahl D.R., Opipari A.W., Sundberg T.B., Reddy P., Liu C., Glick G.D., Ferrara J.L. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci. Transl. Med. 2011, 3:67ra8.
50. Gillespie M.A., Gold E.S., Ramsey S.A., Podolsky I., Aderem A., Ranish J.A. An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux. EMBO J. 2015, 34:1244-1258.
51. Haas R., Smith J., Rocher-Ros V., Nadkarni S., Montero-Melendez T., D'Acquisto F., Bland E.J., Bombardieri M., Pitzalis C., Perretti M., et al. Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions. PLoS Biol. 2015, 13:e1002202.
52. Han J.M., Patterson S.J., Speck M., Ehses J.A., Levings M.K. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J. Immunol. 2014, 192:623-629.
53. Harms M., Seale P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 2013, 19:1252-1263.
54. Helderman J.H. Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. J. Clin. Invest. 1981, 67:1636-1642.
55. Henson S.M., Akbar A.N. Memory T-cell homeostasis and senescence during aging. Adv. Exp. Med. Biol. 2010, 684:189-197.
56. + T cells. J. Clin. Invest. 2014, 124:4004-4016.
57. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
58. Hu X., Wang Y., Hao L.Y., Liu X., Lesch C.A., Sanchez B.M., Wendling J.M., Morgan R.W., Aicher T.D., Carter L.L., et al. Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists. Nat. Chem. Biol. 2015, 11:141-147.
59. Huang W., Metlakunta A., Dedousis N., Zhang P., Sipula I., Dube J.J., Scott D.K., O'Doherty R.M. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010, 59:347-357.
60. Huang S.C., Everts B., Ivanova Y., O'Sullivan D., Nascimento M., Smith A.M., Beatty W., Love-Gregory L., Lam W.Y., O'Neill C.M., et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 2014, 15:846-855.
61. Ichiki T., Sunagawa K. Novel roles of hypoxia response system in glucose metabolism and obesity. Trends Cardiovasc. Med. 2014, 24:197-201.
62. Ip B.C., Hogan A.E., Nikolajczyk B.S. Lymphocyte roles in metabolic dysfunction: of men and mice. Trends Endocrinol. Metab. 2015, 26:91-100.
63. Isoda K., Young J.L., Zirlik A., MacFarlane L.A., Tsuboi N., Gerdes N., Schönbeck U., Libby P. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26:611-617.
64. Johnson K.M., Chen X., Boitano A., Swenson L., Opipari A.W., Glick G.D. Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chem. Biol. 2005, 12:485-496.
65. Joshi N., Caputo G.M., Weitekamp M.R., Karchmer A.W. Infections in patients with diabetes mellitus. N. Engl. J. Med. 1999, 341:1906-1912.
66. Kagami S., Owada T., Kanari H., Saito Y., Suto A., Ikeda K., Hirose K., Watanabe N., Iwamoto I., Nakajima H. Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells. Int. Immunol. 2009, 21:679-689.
67. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
68. Kannan Y., Sundaram K., Aluganti Narasimhulu C., Parthasarathy S., Wewers M.D. Oxidatively modified low density lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in human monocytes but not in macrophages. J. Biol. Chem. 2012, 287:23479-23488.
69. Kim Y.C., Kim K.K., Shevach E.M. Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction. Immunology 2010, 130:484-493.
70. Kjer-Nielsen L., Patel O., Corbett A.J., Le Nours J., Meehan B., Liu L., Bhati M., Chen Z., Kostenko L., Reantragoon R., et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012, 491:717-723.
71. Kleinnijenhuis J., Quintin J., Preijers F., Joosten L.A., Ifrim D.C., Saeed S., Jacobs C., van Loenhout J., de Jong D., Stunnenberg H.G., et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl. Acad. Sci. USA 2012, 109:17537-17542.
72. Koseki M., Hirano K., Masuda D., Ikegami C., Tanaka M., Ota A., Sandoval J.C., Nakagawa-Toyama Y., Sato S.B., Kobayashi T., et al. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages. J. Lipid Res. 2007, 48:299-306.
73. Kratz M., Coats B.R., Hisert K.B., Hagman D., Mutskov V., Peris E., Schoenfelt K.Q., Kuzma J.N., Larson I., Billing P.S., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab. 2014, 20:614-625.
74. Kwak B., Mulhaupt F., Myit S., Mach F. Statins as a newly recognized type of immunomodulator. Nat. Med. 2000, 6:1399-1402.
75. La Cava A., Matarese G. The weight of leptin in immunity. Nat. Rev. Immunol. 2004, 4:371-379.
76. Lanna A., Henson S.M., Escors D., Akbar A.N. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat. Immunol. 2014, 15:965-972.
77. Le Bourhis L., Guerri L., Dusseaux M., Martin E., Soudais C., Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol. 2011, 32:212-218.
78. Lefterova M.I., Haakonsson A.K., Lazar M.A., Mandrup S. PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol. Metab. 2014, 25:293-302.
79. Lovett-Racke A.E., Hussain R.Z., Northrop S., Choy J., Rocchini A., Matthes L., Chavis J.A., Diab A., Drew P.D., Racke M.K. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J. Immunol. 2004, 172:5790-5798.
80. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184.
81. Lv S., Liu Y., Zou Z., Li F., Zhao S., Shi R., Bian R., Tian H. The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis. Clin. Exp. Rheumatol. 2015, 33:69-76.
82. Lynch L., Michelet X., Zhang S., Brennan P.J., Moseman A., Lester C., Besra G., Vomhof-Dekrey E.E., Tighe M., Koay H.F., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 2015, 16:85-95.
83. Ma X., Hua J., Mohamood A.R., Hamad A.R., Ravi R., Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 2007, 46:1519-1529.
84. MacIver N.J., Michalek R.D., Rathmell J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013, 31:259-283.
85. Madiraju A.K., Erion D.M., Rahimi Y., Zhang X.M., Braddock D.T., Albright R.A., Prigaro B.J., Wood J.L., Bhanot S., MacDonald M.J., et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 2014, 510:542-546.
86. Magalhaes I., Pingris K., Poitou C., Bessoles S., Venteclef N., Kiaf B., Beaudoin L., Da Silva J., Allatif O., Rossjohn J., et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J. Clin. Invest. 2015, 125:1752-1762.
87. Mandard S., Patsouris D. Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors. PPAR Res. 2013, 2013:613864.
88. Marx N., Duez H., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 2004, 94:1168-1178.
89. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., Schilter H.C., Rolph M.S., Mackay F., Artis D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
90. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013, 17:851-859.
91. Mauro V.F. Clinical pharmacokinetics and practical applications of simvastatin. Clin. Pharmacokinet. 1993, 24:195-202.
92. McNelis J.C., Olefsky J.M. Macrophages, immunity, and metabolic disease. Immunity 2014, 41:36-48.
93. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., Sullivan S.A., Nichols A.G., Rathmell J.C. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 2011, 186:3299-3303.
94. Miura K., Yang L., van Rooijen N., Ohnishi H., Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G1310-G1321.
95. Murooka T.T., Rahbar R., Platanias L.C., Fish E.N. CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1. Blood 2008, 111:4892-4901.
96. Murray H.W. Interferon-gamma and host antimicrobial defense: current and future clinical applications. Am. J. Med. 1994, 97:459-467.
97. Nath N., Khan M., Paintlia M.K., Singh I., Hoda M.N., Giri S. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J. Immunol. 2009, 182:8005-8014.
98. Netea M.G., Quintin J., van der Meer J.W. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011, 9:355-361.
99. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
100. Norata G.D., Pirillo A., Ammirati E., Catapano A.L. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 2012, 220:11-21.
101. O'Neill L.A., Hardie D.G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013, 493:346-355.
102. O'Sullivan D., van der Windt G.J., Huang S.C., Curtis J.D., Chang C.H., Buck M.D., Qiu J., Smith A.M., Lam W.Y., DiPlato L.M., et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 2014, 41:75-88.
103. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
104. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18:363-374.
105. Palsson-McDermott E.M., Curtis A.M., Goel G., Lauterbach M.A., Sheedy F.J., Gleeson L.E., van den Bosch M.W., Quinn S.R., Domingo-Fernandez R., Johnston D.G., et al. Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015, 21:65-80.
106. Passos J.F., Von Zglinicki T. Oxygen free radicals in cell senescence: are they signal transducers?. Free Radic. Res. 2006, 40:1277-1283.
107. Patel O., Kjer-Nielsen L., Le Nours J., Eckle S.B., Birkinshaw R., Beddoe T., Corbett A.J., Liu L., Miles J.J., Meehan B., et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat. Commun. 2013, 4:2142.
108. Pearce E.L., Pearce E.J. Metabolic pathways in immune cell activation and quiescence. Immunity 2013, 38:633-643.
109. Pirillo A., Catapano A.L., Norata G.D. HDL in infectious diseases and sepsis. Handbook Exp. Pharmacol. 2015, 224:483-508.
110. Pollizzi K.N., Powell J.D. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 2014, 14:435-446.
111. Prieur X., Mok C.Y., Velagapudi V.R., Núñez V., Fuentes L., Montaner D., Ishikawa K., Camacho A., Barbarroja N., O'Rahilly S., et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 2011, 60:797-809.
112. Procaccini C., De Rosa V., Galgani M., Abanni L., Calì G., Porcellini A., Carbone F., Fontana S., Horvath T.L., La Cava A., Matarese G. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 2010, 33:929-941.
113. Qiu Y., Nguyen K.D., Odegaard J.I., Cui X., Tian X., Locksley R.M., Palmiter R.D., Chawla A. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014, 157:1292-1308.
114. Quintin J., Saeed S., Martens J.H., Giamarellos-Bourboulis E.J., Ifrim D.C., Logie C., Jacobs L., Jansen T., Kullberg B.J., Wijmenga C., et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012, 12:223-232.
115. Reinoso R.F., Sánchez Navarro A., García M.J., Prous J.R. Preclinical pharmacokinetics of statins. Methods Find. Exp. Clin. Pharmacol. 2002, 24:593-613.
116. Remaley A.T., Norata G.D., Catapano A.L. Novel concepts in HDL pharmacology. Cardiovasc. Res. 2014, 103:423-428.
117. Rong X., Albert C.J., Hong C., Duerr M.A., Chamberlain B.T., Tarling E.J., Ito A., Gao J., Wang B., Edwards P.A., et al. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell Metab. 2013, 18:685-697.
118. Saeed S., Quintin J., Kerstens H.H., Rao N.A., Aghajanirefah A., Matarese F., Cheng S.C., Ratter J., Berentsen K., van der Ent M.A., et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014, 345:1251086.
119. Sala F., Cutuli L., Grigore L., Pirillo A., Chiesa G., Catapano A.L., Norata G.D. Prevalence of classical CD14++/CD16- but not of intermediate CD14++/CD16+ monocytes in hypoalphalipoproteinemia. Int. J. Cardiol. 2013, 168:2886-2889.
120. Santori F.R., Huang P., van de Pavert S.A., Douglass E.F., Leaver D.J., Haubrich B.A., Keber R., Lorbek G., Konijn T., Rosales B.N., et al. Identification of natural RORγ ligands that regulate the development of lymphoid cells. Cell Metab. 2015, 21:286-297.
121. Sarchielli P., Greco L., Floridi A., Floridi A., Gallai V. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch. Neurol. 2003, 60:1082-1088.
122. Sarikonda G., Pettus J., Phatak S., Sachithanantham S., Miller J.F., Wesley J.D., Cadag E., Chae J., Ganesan L., Mallios R., et al. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J. Autoimmun. 2014, 50:77-82.
123. Schönbeck U., Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?. Circulation 2004, 109(21, Suppl 1):II18-II26.
124. Sharon G., Garg N., Debelius J., Knight R., Dorrestein P.C., Mazmanian S.K. Specialized metabolites from the microbiome in health and disease. Cell Metab. 2014, 20:719-730.
125. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
126. Sheedy F.J., Grebe A., Rayner K.J., Kalantari P., Ramkhelawon B., Carpenter S.B., Becker C.E., Ediriweera H.N., Mullick A.E., Golenbock D.T., et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 2013, 14:812-820.
127. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
128. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 2011, 208:1367-1376.
129. Sina C., Gavrilova O., Förster M., Till A., Derer S., Hildebrand F., Raabe B., Chalaris A., Scheller J., Rehmann A., et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. 2009, 183:7514-7522.
130. Sinclair L.V., Finlay D., Feijoo C., Cornish G.H., Gray A., Ager A., Okkenhaug K., Hagenbeek T.J., Spits H., Cantrell D.A. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 2008, 9:513-521.
131. Singh N., Gurav A., Sivaprakasam S., Brady E., Padia R., Shi H., Thangaraju M., Prasad P.D., Manicassamy S., Munn D.H., et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40:128-139.
132. Singhal A., Jie L., Kumar P., Hong G.S., Leow M.K., Paleja B., Tsenova L., Kurepina N., Chen J., Zolezzi F., et al. Metformin as adjunct antituberculosis therapy. Sci. Transl. Med. 2014, 6:263ra159.
133. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly-Y M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.
134. Sniderman A.D., Tsimikas S., Fazio S. The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies. J. Am. Coll. Cardiol. 2014, 63:1935-1947.
135. Spann N.J., Glass C.K. Sterols and oxysterols in immune cell function. Nat. Immunol. 2013, 14:893-900.
136. Stentz F.B., Kitabchi A.E. Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr. Drug Targets 2003, 4:493-503.
137. Stienstra R., Mandard S., Tan N.S., Wahli W., Trautwein C., Richardson T.A., Lichtenauer-Kaligis E., Kersten S., Müller M. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver. J. Hepatol. 2007, 46:869-877.
138. Stienstra R., Saudale F., Duval C., Keshtkar S., Groener J.E., van Rooijen N., Staels B., Kersten S., Müller M. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 2010, 51:511-522.
139. Sutti S., Jindal A., Locatelli I., Vacchiano M., Gigliotti L., Bozzola C., Albano E. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 2014, 59:886-897.
140. Syn W.K., Oo Y.H., Pereira T.A., Karaca G.F., Jung Y., Omenetti A., Witek R.P., Choi S.S., Guy C.D., Fearing C.M., et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 2010, 51:1998-2007.
141. Tall A.R., Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 2015, 15:104-116.
142. Tan J., McKenzie C., Potamitis M., Thorburn A.N., Mackay C.R., Macia L. The role of short-chain fatty acids in health and disease. Adv. Immunol. 2014, 121:91-119.
143. Taub D.D., Hesdorffer C.S., Ferrucci L., Madara K., Schwartz J.B., Goetzl E.J. Distinct energy requirements for human memory CD4 T-cell homeostatic functions. FASEB J. 2013, 27:342-349.
144. Thorburn A.N., Macia L., Mackay C.R. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 2014, 40:833-842.
145. Thurnher M., Gruenbacher G. T lymphocyte regulation by mevalonate metabolism. Sci. Signal. 2015, 8:re4.
146. Tisell A., Leinhard O.D., Warntjes J.B., Aalto A., Smedby Ö., Landtblom A.M., Lundberg P. Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. PLoS ONE 2013, 8:e61817.
147. Tosello-Trampont A.C., Landes S.G., Nguyen V., Novobrantseva T.I., Hahn Y.S. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J. Biol. Chem. 2012, 287:40161-40172.
148. Tousoulis D., Psarros C., Demosthenous M., Patel R., Antoniades C., Stefanadis C. Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins. J. Am. Coll. Cardiol. 2014, 63:2491-2502.
149. Tremblay K., Méthot J., Brisson D., Gaudet D. Etiology and risk of lactescent plasma and severe hypertriglyceridemia. J. Clin. Lipidol. 2011, 5:37-44.
150. Ulivieri C., Baldari C.T. Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases. Pharmacol. Res. 2014, 88:41-52.
151. Vasanthakumar A., Moro K., Xin A., Liao Y., Gloury R., Kawamoto S., Fagarasan S., Mielke L.A., Afshar-Sterle S., Masters S.L., et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 2015, 16:276-285.
152. Viardot A., Grey S.T., Mackay F., Chisholm D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 2007, 148:346-353.
153. Viollet B., Guigas B., Sanz Garcia N., Leclerc J., Foretz M., Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin. Sci. 2012, 122:253-270.
154. Wahl D.R., Byersdorfer C.A., Ferrara J.L., Opipari A.W., Glick G.D. Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation. Immunol. Rev. 2012, 249:104-115.
155. Walley K.R., Thain K.R., Russell J.A., Reilly M.P., Meyer N.J., Ferguson J.F., Christie J.D., Nakada T.A., Fjell C.D., Thair S.A., et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci. Transl. Med. 2014, 6:258ra143.
156. Wang R., Green D.R. Metabolic checkpoints in activated T cells. Nat. Immunol. 2012, 13:907-915.
157. Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., Cottens S., Takada Y., Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 2001, 7:687-692.
158. Wendel M., Paul R., Heller A.R. Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med. 2007, 33:25-35.
159. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17:610-617.
160. Wolf M.J., Adili A., Piotrowitz K., Abdullah Z., Boege Y., Stemmer K., Ringelhan M., Simonavicius N., Egger M., Wohlleber D., et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 2014, 26:549-564.
161. Wong S.L., Demers M., Martinod K., Gallant M., Wang Y., Goldfine A.B., Kahn C.R., Wagner D.D. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat. Med. 2015, 21:815-819.
162. Wree A., Broderick L., Canbay A., Hoffman H.M., Feldstein A.E. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 2013, 10:627-636.
163. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., Chawla A., Locksley R.M. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
164. Xu X., Grijalva A., Skowronski A., van Eijk M., Serlie M.J., Ferrante A.W. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 2013, 18:816-830.
165. Yang K., Chi H. mTOR and metabolic pathways in T cell quiescence and functional activation. Semin. Immunol. 2012, 24:421-428.
166. Yin Y., Choi S.C., Xu Z., Perry D.J., Seay H., Croker B.P., Sobel E.S., Brusko T.M., Morel L. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 2015, 7:274ra18.
167. Yvan-Charvet L., Welch C., Pagler T.A., Ranalletta M., Lamkanfi M., Han S., Ishibashi M., Li R., Wang N., Tall A.R. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 2008, 118:1837-1847.
168. Yvan-Charvet L., Pagler T., Gautier E.L., Avagyan S., Siry R.L., Han S., Welch C.L., Wang N., Randolph G.J., Snoeck H.W., Tall A.R. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010, 328:1689-1693.
169. Zeng H., Yang K., Cloer C., Neale G., Vogel P., Chi H. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 2013, 499:485-490.
170. Zhao G.J., Yin K., Fu Y.C., Tang C.K. The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol. Med. 2012, 18:149-158.
171. Zheng Y., Collins S.L., Lutz M.A., Allen A.N., Kole T.P., Zarek P.E., Powell J.D. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J. Immunol. 2007, 178:2163-2170.
172. Zhu X., Westcott M.M., Bi X., Liu M., Gowdy K.M., Seo J., Cao Q., Gebre A.K., Fessler M.B., Hiltbold E.M., Parks J.S. Myeloid cell-specific ABCA1 deletion protects mice from bacterial infection. Circ. Res. 2012, 111:1398-1409.
173. Zilverschoon G.R., Tack C.J., Joosten L.A., Kullberg B.J., van der Meer J.W., Netea M.G. Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int. J. Obes. 2008, 32:1407-1414.